INCYTE CORP is 1.6x more valuable than Medpace Holdings, Inc. by market capitalization ($21.06 B vs $13.30 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MEDP | INCY |
|---|---|---|
| Market cap | $13.30 B | $21.06 B |
| US-listed rank | #785 | #601 |
| Revenue (latest FY) | $2.53B | $5.14B |
| Net income (latest FY) | $451.12M | $1.29B |
| Net margin | 17.8% | 25.0% |
| P/E (trailing FY) | 29.5 | 16.4 |
| SEC filings | 874 | 2,536 |
INCYTE CORP is 1.6x more valuable than Medpace Holdings, Inc. by market capitalization ($21.06 B vs $13.30 B).
In their latest fiscal years, Medpace Holdings, Inc. reported $2.53B in revenue while INCYTE CORP reported $5.14B.
Full pages: Medpace Holdings, Inc. and INCYTE CORP, or browse the full rankings.